Erlotinib Hydrochloride CAS 183319-69-9 Kev Ntshiab > 99.0% (HPLC)
Ua cov chaw tsim khoom thiab cov chaw muag khoom ntawm Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-one CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Tshuaj npe | Erlotinib Hydrochloride |
Synonyms | Erlotinib HCl;Tarceva;CP-358774 Hydrochloride;6,7-Bis(2-methoxyethoxy)-4-(3-ethylanilinino) quinazoline Hydrochloride;N-(3-Ethynylphe nyl) [6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl |
CAS Nr | 183319-69-9 |
CAT Number | Qauv TSIS MUAJ: RF-PI2242 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C22H24ClN3O4 |
Molecular Luj | 429.90 Nws |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Crystalline Hmoov |
Kev txheeb xyuas | A: IR: Sib tham rau Reference Spectrum B: HPLC: Sib Tham rau Reference RT |
Solubility | Soluble me ntsis hauv dej, me ntsis soluble hauv Methanol thiab xyaum insoluble hauv Acetonitrile, Acetone, Ethyl Acetate thiab Hexane |
Melting Point | 223.0 ~ 229.0 ℃ |
Poob rau ziab | <0.50% |
Residue ntawm Ignition | <0.20% |
Hnyav Hlau | <20 ppm |
Ib leeg Impurity | <0.50% |
Tag nrho cov impurities | <1.00% |
Residual Solvents | |
Pyridine | <4000ppm |
Chloroform | <4000ppm |
DMF | <3000ppm |
Purity / Analysis Method | > 99.0% |
Assay / Analysis Method | 98.5% ~ 101.0% (Cau ntawm Anhydrous Basis) |
Test Standard | Enterprise Standard |
Kev siv | API |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
Erlotinib Hydrochloride (CAS: 183319-69-9) yog ib tug me me molecule ntawm epidermal loj hlob yam tseem ceeb receptor tyrosine kinase reversible inhibitor, yog tsuas yog siv nyob rau hauv kev kho mob ntawm lub zos advanced los yog metastatic tsis me me cell ntsws cancer thiab thib ob-kab los yog peb kab kev kho mob. mob qog noj ntshav pancreatic.Erlotinib Hydrochloride tau pom zoo nyob rau lub Kaum Ib Hlis, 2004, rau kev kho mob ntawm kev mob qog noj ntshav siab lossis metastatic uas tsis yog mob qog noj ntshav.Nws belongs rau tib chav kawm xws li Gefitinib, lwm quinazoline tau pom zoo rau kev kho mob qog noj ntshav siab, tab sis nrog kev txhim kho pharmacokinetic.Lub molecule tau pib los ntawm Pfizer thiab kev txhim kho pib hauv kev koom tes nrog OSI, uas suav tias muaj cai tag nrho rau cov tshuaj thaum Pfizer koom nrog Warner Lambert.Tom qab ntawd, Genentech / Roche tau mus rau hauv daim ntawv cog lus nrog OSI los tsim thiab ua lag luam cov tshuaj hauv Asmeskas thiab thoob ntiaj teb.Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor.Antineoplastic.Erlotinib Hydrochloride yog HER1 / EGFR inhibitor nrog IC50 ntawm 2 nM.Erlotinib HCl muaj xws li 25-, 100-, thiab 150-mg ntsiav tshuaj rau kev tswj hwm.